IVF Embryo Grading: What 4AA, 3BB, 4BB and 5BC Mean
Key Takeaways
An embryo grade describes how a blastocyst looks under the microscope. The number shows how far it has expanded. The two letters grade its inner cell mass and its outer layer (trophectoderm). A 4AA or 5AA usually looks stronger than a 4BB or 5BC, but no grade promises a live birth. Your age, the embryo's chromosomes, the day it reached this stage, how the lab grades, and conditions at transfer all affect the result.
Key evidence: ESHRE/Alpha Istanbul Consensus update (2025) Blastocyst quality and reproductive outcomes — multinational study (2023)
On this page
- What embryo grading really means
- How to read the number
- How to read the letters
- Is 4AA always better than 3BB or 4BB?
- What lower grades do not mean
- Why morphology cannot determine chromosome status
- Other factors that influence success
- Clinical Note
- Practical interpretation
- Frequently asked questions for Dr. Aksoy
IVF embryo grading: what the lab report really means
When a report lands with codes like 4AA, 4BB or 5BC, it is easy to read it like a school grade. Many patients do. In reality, embryo grading gives embryologists and clinicians a shared language for describing blastocysts and deciding which one to discuss first for transfer or freezing. It helps structure the conversation. It does not, on its own, tell you what will happen.
The familiar Gardner system supplies the number-and-letter code. The 2011 Istanbul consensus gave laboratories common minimum criteria, and the 2025 ESHRE/Alpha update refined them with newer evidence and recommends Gardner scoring for blastocysts. That shared vocabulary makes day-to-day decisions clearer and helps research from different centres fit together.
Grading is still partly subjective. The same embryo may receive a slightly different grade from a different embryologist or laboratory, so these codes are not standardised test scores for comparing clinics.
No single code carries one universal success rate. Age, chromosomal status, transfer conditions and the rest of the embryo cohort all change the picture. For a broader view of how outcomes vary by age and transfer type, see clinical success rates explained.
What the number means
The number in a grade such as 4AA or 5BC describes how far the blastocyst has expanded or hatched. The 2025 update of the Istanbul consensus recommends the Gardner blastocyst scoring system and defines six stages:
| Stage | What the embryologist sees |
|---|---|
| 1 | Early blastocyst: the fluid-filled cavity (blastocoel) takes up less than half of the embryo |
| 2 | Blastocyst: the cavity takes up half of the embryo or more |
| 3 | Full blastocyst: the cavity fills the embryo completely |
| 4 | Expanded blastocyst: the cavity is larger than in the earlier stages and the outer shell (zona) is clearly thinning |
| 5 | Hatching blastocyst: the trophectoderm is starting to push out through the zona |
| 6 | Hatched blastocyst: the blastocyst has completely left the zona |
A 5AA or 5BB is therefore a hatching blastocyst.
Think of expansion as a developmental stage, not a stand-alone quality ranking. A higher number may look favourable when similar embryos are assessed at comparable times, but a 5 is not automatically better than a 4. When the embryo was checked, which blastocyst day it reached, and how it re-expands after warming all matter. The number alone does not tell you whether the embryo is chromosomally normal.
What the letters mean
The first letter refers to the inner cell mass (ICM) — the part expected to form the fetus.
The second letter refers to the trophectoderm (TE) — the cells expected to help form the placenta.
The same consensus defines the letters as follows:
| Grade | Inner cell mass (first letter) | Trophectoderm (second letter) |
|---|---|---|
| A | Prominent and easy to see, with many tightly packed cells | Many cells forming a cohesive layer |
| B | Easy to see, with several loosely grouped cells | A moderate number of cells forming a loose layer |
| C | Very few cells visible | Few, larger cells with a poorly formed layer |
| D | No visible cells, or degenerating cells | Sparse or degenerating cells around the inner cell mass |
The 2025 consensus reserves D for non-viable blastocysts with degenerative features or no distinct inner cell mass. That is different from C: blastocysts with a grade C inner cell mass or trophectoderm can be viable and may still be considered for clinical use.
Both letters matter. In many observational studies, trophectoderm grade has shown the strongest association with live birth, but the findings are not completely consistent, and the ESHRE/Alpha consensus notes that the relative weight of the ICM, expansion and developmental day is not settled in every context. Neither letter should be read alone.
Cell-division pattern, fragmentation and the way the blastocyst expands all feed into this assessment. It remains a snapshot from one moment in development.
So is a 4AA always better than a 3BB or 4BB?
Morphologically, a 4AA or 5AA is usually considered more favourable than a 3BB or 4BB in large cohort studies. The gap is not absolute. A 4BB embryo can still lead to a healthy pregnancy. A beautiful-looking embryo can still fail if it is aneuploid or the uterine environment is unfavourable.
What lower grades do not mean
A lower grade does not automatically mean:
- the embryo is non-viable
- pregnancy is impossible
- transfer is pointless
Many successful pregnancies come from BB embryos, and even BC embryos may still be transferred in selected situations.
Why morphology cannot determine chromosome status
Morphology cannot diagnose whether an embryo is euploid (with the expected number of chromosomes) or aneuploid. Better-looking embryos may be more likely to be euploid, but appearance is not accurate enough to settle chromosome status on its own. When PGT-A is used for an appropriate clinical indication, its result and its limits are weighed separately from morphology.
Morphology should therefore be interpreted alongside maternal age, the embryo’s developmental day, the rest of the embryo cohort and, when available, appropriately interpreted PGT-A findings.
Other factors that influence success
Even a strong embryo grade does not act in isolation. Outcome also depends on:
- maternal age
- gamete-related factors, including egg and sperm biology
- the day on which the embryo reached the blastocyst stage (Day 5, 6 or 7)
- appropriate preparation of the endometrium for the chosen transfer protocol
- uterine cavity factors
- lab conditions and embryology practice
Day-7 blastocysts may have lower average probabilities than Day-5 embryos, but live births still occur.
Clinical Note
Dr Aksoy’s perspective: what can and cannot be changed
When patients ask what they can do to improve an embryo’s grade, the honest answer is that our room for manoeuvre is limited. Morphology matters for implantation and pregnancy potential, but we cannot reliably “upgrade” a grade with a medicine, supplement or laboratory add-on.
Egg and sperm quality matter, as do age, genetics, culture conditions and other biological factors that do not always separate neatly. Our practical job is to tailor stimulation so that we obtain mature oocytes safely, then protect those oocytes and embryos with consistent laboratory care. That work matters. It still cannot rewrite the underlying biology of an egg or sperm cell.
Many supplements, medication changes and laboratory techniques have been tried. Some have a specific role in selected patients, but none has been shown to consistently turn a lower-grade embryo into a higher-grade one. That distinction matters when an IVF add-on is sold as a way to “improve quality”.
A grade changes probability, not possibility. If an embryo remains clinically usable, a lower grade does not reduce its chance to zero. We look at it alongside the rest of the embryo cohort and the patient’s circumstances, rather than dismissing it because the code looks disappointing.
Day-5 4BB or Day-6 4AA: which would I transfer first?
Without PGT-A, I would tend to transfer the Day-5 4BB embryo first. Reaching the blastocyst stage on Day 5 is important prognostic information that points to good developmental speed, and Day-5 blastocysts generally have better live birth outcomes than Day-6 blastocysts (meta-analysis, 2019).
The difference between these two embryos is not sharp, though. The Day-6 4AA has better morphology, and studies show that results with good-quality Day-6 embryos can come close to those with lower-quality Day-5 embryos (euploid transfer cohort, 2024).
The information that would change my decision most is the embryo’s chromosomal status. If I knew the Day-6 4AA was euploid, I would put it first, because that is stronger information than morphology or the day of development. Without PGT-A, the laboratory’s own results and how the embryo re-expands after warming can also change my choice.
Practical interpretation of common grades
Read the grade together with the blastocyst day. “Day-5 4BB” tells you more than “4BB” alone.
| Grade pattern | How to read it |
|---|---|
| 4AA / 5AA | Strong morphology, but still not a guarantee. Morphology does not determine chromosome status; PGT-A, when used, estimates the chromosomes tested but is not an absolute guarantee either. |
| 4AB / 4BA / 5AB | Still very favourable in many cases. |
| 3BB / 4BB / 5BB | Common transferable embryos with real pregnancy potential. The number shows the stage of expansion; a 5BB is not automatically better than a 4BB. |
| BC / CB / CC patterns | Weaker morphology, but not automatically ruled out in every situation. |
The meaning of each grade changes with the other embryos available and whether genetic results are known. A report showing only one 4BB embryo or one 5AA embryo still needs the wider clinical picture before anyone treats the code as destiny.
Related reading
- Can preimplantation genetic testing be used for sex selection?
- PGT-M for monogenic diseases
- Embryoscope and AI embryo selection
- IVF risks and practical considerations
Frequently Asked Questions for Dr. Aksoy
Is there a success rate for a 3BB, 4AA or 5BC embryo?
It would not be right to give one reliable pregnancy percentage for any of these codes that applies regardless of the patient. The number describes how far the blastocyst has expanded or started to hatch; the letters describe how the inner cell mass and trophectoderm look under the microscope.
In general, AA morphology is associated with a better prognosis than BB, and BB with a better prognosis than grades that include a C (multinational cohort, 2023). But age, whether the embryo reached the blastocyst stage on Day 5 or Day 6, the PGT-A result, and laboratory and transfer conditions can change that probability considerably (ESHRE/Alpha, 2025). Morphology is a ranking tool, not a test that says “this embryo has an X% chance of pregnancy”.
Is a 3BB (or 4BB or 5BB) embryo good?
Yes. A BB blastocyst is generally considered a transferable, good embryo with a reasonable prognosis. The difference between 3BB, 4BB and 5BB mainly shows how far the blastocyst has expanded or has begun to emerge from the zona pellucida, its outer shell. A 5BB is not automatically of better quality than a 4BB. To judge an embryo, the number and the two letters have to be read together.
Does it matter whether the embryo reached the blastocyst stage on Day 5 or Day 6?
It does, but a Day-6 embryo is not a bad embryo. Across IVF patients in general, Day-5 blastocysts are associated with higher clinical pregnancy and live birth rates (meta-analysis, 2019).
When PGT-A has been done and both embryos are known to be euploid, the difference narrows. In studies reviewed by the ASRM, Day-5 and Day-6 euploid embryos gave similar results, while a more recent retrospective study still found an advantage for Day 5 (euploid transfer cohort, 2024). The speed of development is helpful information when choosing, but on its own it does not settle the decision.
If the embryo is euploid after PGT-A, does its grade still matter?
Yes, but it carries less weight. PGT-A gives information about the number of chromosomes; morphology adds a separate layer of information about how the embryo has developed. When there is more than one euploid embryo, morphology and the day of development can be used to decide the order of transfer.
Some studies show that better morphology is associated with a higher live birth rate even among euploid embryos (euploid transfer cohort, 2024). How much each feature matters varies between studies; in one PGT-A cohort, only the trophectoderm grade remained linked to live birth (PGT-A cohort, 2025). A euploid embryo with poor morphology can still lead to a healthy live birth.
Is a 5AA better than a 4AA (or a 5BB better than a 4BB)?
I would not simply say that a 5AA is of higher quality. In both 4AA and 5AA, the inner cell mass and the trophectoderm are grade A. The difference between 4 and 5 mainly reflects the stage of expansion or hatching: 4 is an expanded blastocyst, while 5 has begun to emerge from the zona pellucida (Gardner scoring).
A 5AA is therefore at a more advanced stage of development, but that alone does not mean a higher chance of pregnancy. In one PGT-A cohort, grade-5 blastocysts were more often euploid than grade-4 ones (PGT-A cohort, 2025); that still does not make every 5 better than every 4. The same reasoning applies to 4BB and 5BB. When deciding the order of transfer, the day of development, morphology, euploidy and the embryo’s condition after warming should be weighed together.
Sources
- Gardner et al. — Blastocyst scoring system (2000)
- Alpha Scientists and ESHRE — Consensus on embryo assessment (2011)
- ESHRE/Alpha — Revised embryo assessment recommendations (2025)
- Blastocyst quality and reproductive and perinatal outcomes — multinational multicentre study (2023)
- Bourdon et al. — Day 5 versus Day 6 blastocyst transfers: systematic review and meta-analysis, Hum Reprod (2019)
- Thang et al. — Embryo quality and outcomes in single Day-5 versus Day-6 euploid blastocyst transfer, Int J Fertil Steril (2024)
- Chen et al. — Blastocyst morphology, developmental rate, euploidy and live birth in PGT-A cycles, Reprod Sci (2025)
- ESHRE — Good practice recommendations on add-ons in reproductive medicine (2023)
- Haas et al. — Morphometric blastocyst quality evaluation and IVF outcomes (2015)
- ASRM Committee Opinion — PGT-A (2024)
Add as a Preferred Source on Google
You can add draksoyivf.com as one of your preferred health information sources on Google.
The content has been created by Dr. Senai Aksoy and medically approved.